Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniela Castanotto

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 3, 2011
Sensor and sensitivity: a screen for elite shRNAsDaniela Castanotto
Methods in Enzymology|January 13, 2005
Targeting cellular genes with PCR cassettes expressing short interfering RNAsDaniela Castanotto, Lisa Scherer
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 4, 2017
FDA-Approved Oligonucleotide Therapies in 2017Cy A Stein, Daniela Castanotto
Nature|January 23, 2009
The promises and pitfalls of RNA-interference-based therapeuticsDaniela Castanotto, John J Rossi
Methods in Molecular Biology (Clifton, N.J.)|March 16, 2004
Construction and transfection of PCR products expressing siRNAs or shRNAs in mammalian cellsDaniela Castanotto, John J Rossi
Current Opinion in Oncology|September 5, 2014
Antisense oligonucleotides in cancerDaniela Castanotto, Cy A Stein
RNA (New York, N.Y.)|December 3, 2002
Functional siRNA expression from transfected PCR productsDaniela Castanotto, Haitang Li, John J Rossi
Molecular Therapy. Nucleic Acids|January 30, 2017
Defibrotide (Defitelio): A New Addition to the Stockpile of Food and Drug Administration-approved Oligonucleotide DrugsCy Stein, Daniela Castanotto, Amrita Krishnan, et al.
Trends in Pharmacological Sciences|December 15, 2019
Oligonucleotides to the (Gene) Rescue: FDA Approvals 2017-2019Jacqueline Rüger, Silvia Ioannou, Daniela Castanotto, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 28, 2017
6BIO Enhances Oligonucleotide Activity in Cells: A Potential Combinatorial Anti-androgen Receptor Therapy in Prostate Cancer CellsXiaowei Zhang, Daniela Castanotto, Sangkil Nam, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 3, 2011
Sensor and sensitivity: a screen for elite shRNAsDaniela Castanotto
Methods in Enzymology|January 13, 2005
Targeting cellular genes with PCR cassettes expressing short interfering RNAsDaniela Castanotto, Lisa Scherer
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 4, 2017
FDA-Approved Oligonucleotide Therapies in 2017Cy A Stein, Daniela Castanotto
Nature|January 23, 2009
The promises and pitfalls of RNA-interference-based therapeuticsDaniela Castanotto, John J Rossi
Methods in Molecular Biology (Clifton, N.J.)|March 16, 2004
Construction and transfection of PCR products expressing siRNAs or shRNAs in mammalian cellsDaniela Castanotto, John J Rossi
Current Opinion in Oncology|September 5, 2014
Antisense oligonucleotides in cancerDaniela Castanotto, Cy A Stein
RNA (New York, N.Y.)|December 3, 2002
Functional siRNA expression from transfected PCR productsDaniela Castanotto, Haitang Li, John J Rossi
Molecular Therapy. Nucleic Acids|January 30, 2017
Defibrotide (Defitelio): A New Addition to the Stockpile of Food and Drug Administration-approved Oligonucleotide DrugsCy Stein, Daniela Castanotto, Amrita Krishnan, et al.
Trends in Pharmacological Sciences|December 15, 2019
Oligonucleotides to the (Gene) Rescue: FDA Approvals 2017-2019Jacqueline Rüger, Silvia Ioannou, Daniela Castanotto, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 28, 2017
6BIO Enhances Oligonucleotide Activity in Cells: A Potential Combinatorial Anti-androgen Receptor Therapy in Prostate Cancer CellsXiaowei Zhang, Daniela Castanotto, Sangkil Nam, et al.
Pageof 3